Healthdirect Australia is not responsible for the content and advertising on the external website you are now entering.
Active ingredients: digoxin-specific antibody fragment f(ab)
What it is used for
Digoxin-specific antibody fragment F(Ab) (Ovine) DigiFab½ is indicated for the treatment of known (or strongly suspected) life-threatening digoxin toxicity associated with ventricular arrhythmias, progressive bradycardia, or second or third degree heart block not responsive to atropine, and where additional measures besides withdrawal of digoxin and correction of serum electrolyte abnormalities are considered necessary. Consequences of multiple dosing with DigiFab have not been evaluated.
How to take it
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
- The way to take this medicine: Intravenous
- Store at 2 to 8 degrees Celsius
- Do not Freeze
- Reconstituted Solution see label for shelf life
- Shelf lifetime is 3 Years.
Always read the label. If symptoms persist see your healthcare professional.
White or off-white friable cake.,Colourless to pale yellow solution when reconstituted.
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Pregnant or planning a pregnancy?
For the active ingredient digoxin-specific antibody fragment f(ab)
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
For side effects, taking other medicines and more
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
DigiFab Powder for infusion - myDr.com.au
DigiFab Powder for infusion - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Management of digoxin toxicity | Issue 1 | Volume 39 | Australian Prescriber
Digoxin toxicity can emerge during long-term therapy for heart failure as well as after an overdose.
Read more on Australian Prescriber website